The Role of Pharmacogenetics in Personalising Stroke Care: World Stroke Academy Webinar Chaired by Prof. Simona Sacco
GeneDrive shared on LinkedIn:
”Still time to register for the World Stroke Academy Webinar
In just over two weeks time September 18th 5-6pm (CEST)
For an expert-led webinar exploring the latest evidence and approaches in optimizing antiplatelet therapy for stroke patients.
Chaired by Prof. Simona Sacco, this session will bring together leading voices in the field to address both clinical practice and the role of pharmacogenetics in personalising stroke care.
With keynote sessions on:
‘The Importance of Genetic Testing of CYP2C19 in Stroke Patients’ by Prof. William Newman
‘Current Indications for Dual Antiplatelet Therapy in Acute Stroke Patients’ by Prof. Daniel C. Bezerra”
Register Now!
Stay informed on all coming webinars in the field of stroke with Hemostasis Today.
-
Sep 13, 2025, 10:49Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
-
Sep 13, 2025, 10:23Peter Lenting at BIC 2025: Fantastic Lecture on FVIII Mimetics
-
Sep 13, 2025, 09:54Cihan Ay: ISTH 2026 In Planning!
-
Sep 12, 2025, 06:39Chokri Ben Lamine: Approach to Intra-Operative Bleeding in G6P Deficiency – Key Causes and Management
-
Sep 12, 2025, 05:33Rafael Gomes Highlights Key ESC 2025 CABG Findings: Aspirin Monotherapy Still Best After Surgery
-
Sep 14, 2025, 04:16F8 Gene Variants Affect Desmopressin Response in Female Hemophilia A Carriers
-
Sep 13, 2025, 10:36Drug-Induced Immune Haemolytic Anaemia: A Decade Review by Abdul Mannan
-
Sep 13, 2025, 09:44Christelle Orlando: Type II Antithrombin Deficiency Frequently Underdiagnosed Due to Assay Limitations
-
Sep 13, 2025, 07:18Eric Topol Shares a Study on The Consequences of Our Pervasive Exposure to Micro- and Nanoplastics
-
Sep 13, 2025, 06:30Steven Grover on The Role of FXII in the Pathogenesis of VTE
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 14, 2025, 06:39Abdul Mannan on Factor VIII Aurora: First Natural Gain-of-Function Mutation in Haemophilia A
-
Sep 13, 2025, 13:34Brian O Mahony on 5-Year Roctavian Gene Therapy Data from BIC2025
-
Sep 13, 2025, 10:55José Antonio García Erce: Platelet Program for the Management of the Patient's Blood
-
Sep 13, 2025, 06:49Emna Gouider Belhadjali on the Role of NMOs in Advocating for Equitable Access to Diagnosis for WGBDs
-
Sep 12, 2025, 09:30Arun V J Explains How Blood Donation Rules Differ Worldwide and Why Your Donation Saves Lives Everywhere